111, Inc. Sponsored ADR (NASDAQ:YI) Sees Significant Drop in Short Interest

111, Inc. Sponsored ADR (NASDAQ:YI) was the target of a significant drop in short interest in the month of May. As of May 29th, there was short interest totaling 6,011 shares, a drop of 57.5% from the May 14th total of 14,127 shares. Based on an average daily trading volume, of 21,907 shares, the short-interest ratio is presently 0.3 days. Approximately 0.1% of the company’s stock are short sold.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings lowered shares of 111 from a “sell (d-)” rating to a “sell (e+)” rating in a report on Thursday, June 4th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, 111 presently has an average rating of “Sell”.

Insider Buying and Selling

In other 111 news, Director Jian David Sun sold 111,100 shares of the firm’s stock in a transaction dated Thursday, June 11th. The shares were sold at an average price of $0.23, for a total value of $25,553.00. Following the completion of the sale, the director directly owned 472,011 shares in the company, valued at $108,562.53. This trade represents a 19.05% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 442,820 shares of company stock valued at $105,980 in the last ninety days. Company insiders own 43.90% of the company’s stock.

111 Stock Up 14.3%

Shares of YI stock traded up $0.61 during trading hours on Friday, hitting $4.89. 63,632 shares of the company’s stock traded hands, compared to its average volume of 26,072. The stock’s fifty day simple moving average is $5.92 and its two-hundred day simple moving average is $5.64. 111 has a 12-month low of $2.48 and a 12-month high of $11.17. The stock has a market cap of $42.96 million, a price-to-earnings ratio of -3.49 and a beta of 0.60.

111 Company Profile

111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.

111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.